Novamed, Sanofi submit new market shares in Brazil CADE’s Medley review
Novamed and Sanofi have submitted additional market-share data requested by the Brazilian competition authority in its full-form review of Novamed’s proposed acquisition of Medley, arguing that new therapeutic-indication scenarios don't raise...To view the full article, register now.
Already a subscriber? Click here to view full article